- Trials with a EudraCT protocol (3)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
3 result(s) found for: Fear of falling.
Displaying page 1 of 1.
| EudraCT Number: 2017-001543-13 | Sponsor Protocol Number: HIP-SAP | Start Date*: 2018-03-28 | ||||||||||||||||||||||||||
| Sponsor Name:Morten Tange Kristensen/Hvidovre Hospital | ||||||||||||||||||||||||||||
| Full Title: Preliminary effect and safety of physiotherapy with strength training and protein-dense nutritional supplement in combination with anabolic steroids in cross-continuum rehabilitation of patients wi... | ||||||||||||||||||||||||||||
| Medical condition: Area of investigation is recovery of muscle strength and function following hip fracture surgery. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Population Age: Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
| Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||
| EudraCT Number: 2018-003219-23 | Sponsor Protocol Number: 2844 | Start Date*: 2019-06-28 | ||||||||||||||||
| Sponsor Name:University of Bristol | ||||||||||||||||||
| Full Title: CHIEF-PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson’s Disease): A phase 3 randomised double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease | ||||||||||||||||||
| Medical condition: This trial will investigate the effectiveness of Rivastigmine on prevention of falls in patients with Parkinson's disease | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2011-003053-25 | Sponsor Protocol Number: 1466 | Start Date*: 2012-06-18 | |||||||||||
| Sponsor Name:Research and Enterprise Department | |||||||||||||
| Full Title: A randomised, double blind, placebo controlled trial to evaluate the effect of Rivastigmine on gait in people with Parkinson’s disease who have fallen. | |||||||||||||
| Medical condition: Parkinson's disease | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.